Creating a new noninvasive test to detect retinal problems early
Development of a novel, noninvasive, sensitive measure of retinal dysfunction
['FUNDING_R21'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-11064593
This study is working on a new, easy way to check for early signs of eye problems in people with diabetic retinopathy, so doctors can catch issues before they affect your vision and help prevent vision loss.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-11064593 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a novel, noninvasive method to measure retinal dysfunction, particularly in conditions like diabetic retinopathy. By utilizing advanced imaging techniques, the study aims to identify early signs of retinal damage before patients experience visual symptoms. This approach could lead to timely interventions that may prevent vision loss. The research seeks to create a more accessible diagnostic tool that can be integrated into routine clinical practice.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for diabetic retinopathy, particularly those with diabetes.
Not a fit: Patients with retinal conditions unrelated to diabetic retinopathy or those who have already experienced significant vision loss may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve early detection and treatment of retinal diseases, potentially preventing vision loss in millions of patients.
How similar studies have performed: Previous research using advanced imaging techniques like adaptive optics has shown promise in detecting retinal dysfunction, indicating that this approach may build on established methods.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DUNN, FELICE A — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: DUNN, FELICE A
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.